Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionphosphatidylethanolamine binding

GABARAPL3 GABARAPL1

4.45e-0419332GO:0008429
GeneOntologyMolecularFunctionGABA receptor binding

GABARAPL3 GABARAPL1

4.94e-0420332GO:0050811
GeneOntologyCellularComponentsupramolecular fiber

EML2 MYOM2 GABARAPL3 GABARAPL1 NEB TMEM232 INCENP KIF17 CSPP1

6.30e-051179339GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

EML2 MYOM2 GABARAPL3 GABARAPL1 NEB TMEM232 INCENP KIF17 CSPP1

6.64e-051187339GO:0099081
GeneOntologyCellularComponentmicrotubule

EML2 GABARAPL3 GABARAPL1 INCENP KIF17 CSPP1

1.65e-04533336GO:0005874
GeneOntologyCellularComponentpolymeric cytoskeletal fiber

EML2 GABARAPL3 GABARAPL1 TMEM232 INCENP KIF17 CSPP1

4.26e-04899337GO:0099513
DomainAtg8-like

GABARAPL3 GABARAPL1

8.42e-058332IPR004241
DomainAtg8

GABARAPL3 GABARAPL1

8.42e-058332PF02991
Domain-

STAMBP RPS6KC1

2.33e-04133321.20.58.280
DomainMIT

STAMBP RPS6KC1

2.72e-0414332IPR007330
DomainVWFA

HMCN2 ITGAL

9.20e-0382332PS50234
DomainVWA

HMCN2 ITGAL

9.64e-0384332SM00327
DomainVWF_A

HMCN2 ITGAL

1.32e-0299332IPR002035
Pubmed

Cloning, expression patterns, and chromosome localization of three human and two mouse homologues of GABA(A) receptor-associated protein.

GABARAPL3 GABARAPL1

5.23e-06433211414770
Pubmed

Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.

MYOM2 NEB

3.91e-051033220368620
Pubmed

Molecular diversity of myofibrillar proteins: gene regulation and functional significance.

MYOM2 NEB

5.73e-05123328618961
Pubmed

A human MAP kinase interactome.

NFYA CCDC88A NEB KHDRBS1 STAMBP

8.97e-0548633520936779
Pubmed

gp 120s derived from four syncytium-inducing HIV-1 strains induce different patterns of CD4 association with lymphocyte surface molecules.

ITGAL HLA-E

1.64e-04203329263011
Pubmed

Decoding the fine-scale structure of a breast cancer genome and transcriptome.

PRSS23 STAMBP

2.18e-042333216461635
Pubmed

The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse.

ITGAL HLA-E

4.81e-04343321686571
Pubmed

Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.

CSPP1 KIAA0753

6.01e-043833236674791
Pubmed

Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice.

MYOM2 NEB

6.33e-043933224703692
Pubmed

Genetic composition of the recombinant congenic strains.

ITGAL HLA-E

7.00e-04413328903730
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MYOM2 HMCN2

1.10e-02161182593
GeneFamilyImmunoglobulin like domain containing

MYOM2 HMCN2

1.55e-02193182594
ToppCellCOVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class

MYOM2 PRSS23 ITGAL STK26 HLA-E

1.93e-071773356978a22fef40c8b455342373abe7593f5ede0fa4
ToppCellCOVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class

MYOM2 PRSS23 ITGAL STK26 HLA-E

2.34e-07184335791f1bcb954aadc63d4117c400537d036f68734d
ToppCellCOVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.12e-071953359990440bda7fac5d00ef80444fab07459be625e1
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.20e-071963356beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.20e-07196335f424c45be7f34cbef76e1696dea10c1e3a9af2e0
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.20e-07196335c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.20e-071963359bb87d20c25df0dc8e48bcb32b57f81a3dc1c0cd
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.20e-07196335418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL STK26 HLA-E

3.20e-07196335581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 ITGAL STK26 HLA-E

8.67e-06177334d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 ITGAL STK26 HLA-E

8.67e-06177334f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOM2 ITGAL STK26 HLA-E

8.67e-06177334936ab2b180a052387124f68d0c7f41c0b164e748
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYOM2 ITGAL STK26 HLA-E

8.67e-06177334d5aeda113afaa2425874394610344570c9078478
ToppCell356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 PRSS23 ITGAL HLA-E

8.86e-061783347203149864cc8d5ae25329fdbf15c6b73c3d3595
ToppCellASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

PRSS23 ITGAL STK26 HLA-E

9.26e-06180334857d09446e3e6737e83d0f10bfda2ba282d5ba75
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 PRSS23 ITGAL HLA-E

9.67e-06182334c6172aca2475bf0948a78e39f0dae6388504a915
ToppCellCOVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class

MYOM2 ITGAL STK26 HLA-E

9.88e-0618333422bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYOM2 PRSS23 ITGAL HLA-E

1.05e-05186334e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYOM2 PRSS23 ITGAL HLA-E

1.05e-051863341590fe72badffc79f1d390deb3207116ac2281bb
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYOM2 ITGAL INCENP RPS6KC1

1.08e-051873348c69fd469df2915c56ede534cee3ef23d5f64ebf
ToppCell(210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization)

MYOM2 PRSS23 TMEM232 ITGAL

1.19e-0519233408dc0c019c594da7b9944db8fd706aa7780e6ae9
ToppCell(21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization)

MYOM2 PRSS23 TMEM232 ITGAL

1.19e-05192334b0a573ddde2978485a857b8261ee1ee5ef68ecef
ToppCell3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue

MYOM2 PRSS23 ITGAL HLA-E

1.22e-05193334e790ab76c12f74a13936c231076f1e397283efb3
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYOM2 PRSS23 ITGAL HLA-E

1.22e-05193334db9378c5bb5c27b321957a05dcabf40e97a3b725
ToppCell3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue

MYOM2 PRSS23 ITGAL HLA-E

1.24e-051943347773501e076d470158dbc1d7f10c67152b326eb7
ToppCellBLOOD--(1)_EM_CTLs| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MYOM2 PRSS23 ITGAL HLA-E

1.24e-0519433466583c6cff3814902d6babdea3a2ae962decde65
ToppCell3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue

MYOM2 PRSS23 ITGAL HLA-E

1.24e-051943343337042eef91a49f621058785723228cf4dfdad4
ToppCell(1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

PRSS23 GABARAPL1 ITGAL HLA-E

1.27e-05195334f582b854e5a4c52764aad5abe4e28ea77a7445f7
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue

MYOM2 PRSS23 ITGAL HLA-E

1.27e-05195334e756733cf48768bf40058d6cf9039e52f7563133
ToppCellCOVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class

PRSS23 GABARAPL1 ITGAL HLA-E

1.27e-05195334ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCellT/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class

MYOM2 PRSS23 ITGAL HLA-E

1.27e-051953346124e87cb9061bf8918377fb4a79084079ddfc16
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue

PRSS23 GABARAPL1 ITGAL HLA-E

1.29e-05196334f23c33ad10f933250be98e8389a9aa278e876f96
ToppCell(1)_T_cells-(1)_T_CD8_CytT|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

PRSS23 GABARAPL1 ITGAL HLA-E

1.29e-051963343a4ba9ca84ce6b35038765da8c55812587b58bc2
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYOM2 ITGAL STK26 HLA-E

1.29e-05196334772a5851cbcc36b2075bd2ffbf8c9afa9b4b6eb7
ToppCellmild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PRSS23 GABARAPL1 ITGAL HLA-E

1.32e-051973348b0e4012e25641c3bcd3e9911031e43d9dbbff21
ToppCell343B-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 PRSS23 ITGAL HLA-E

1.32e-05197334e1009fa54d365a7f4345fef836da6076b5c1c3d0
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL HLA-E

1.35e-05198334a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCellhealthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

MYOM2 PRSS23 ITGAL HLA-E

1.35e-05198334d7053a898e04478c577381085f615edaad3cdc5b
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOM2 PRSS23 ITGAL HLA-E

1.35e-05198334a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCellhealthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass

MYOM2 PRSS23 ITGAL HLA-E

1.35e-05198334aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCellHealthy_donor-gd_T|World / disease group, cell group and cell class (v2)

MYOM2 PRSS23 GABARAPL1 ITGAL

1.35e-051983340c3475936f148f2c026501c61b43bcb94d320c48
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL HLA-E

1.35e-0519833476aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYOM2 PRSS23 ITGAL HLA-E

1.35e-05198334df399674345c45738d765a8354ea8d1484572c34
ToppCellCOVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class

MYOM2 PRSS23 ITGAL HLA-E

1.35e-051983346aea5d00c417708f05b6d2dfe5a962d80864f8eb
ToppCellHealthy/Control-NK|World / Disease group and Cell class

MYOM2 PRSS23 ITGAL HLA-E

1.37e-0519933487af9c38938dc2db0f9cf9f3676895d2a8b5d7e6
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-0519933410c8729b779073c3bf808e85958d59147f0be5c5
ToppCellControl-NK|Control / Disease condition and Cell class

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334867fd292f3879982422e840e087bfdb3b21a8715
ToppCellHealthy/Control-NK|Healthy/Control / Disease group and Cell class

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334e7fd91080fca7c31a2d48433791da3c2a4adf14d
ToppCellCOVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCellCOVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-051993347d071c88a003babf6dbdb84dde561fc03c92f375
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334b03539908131308d7bf5036e78c4c840a6a79a17
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-051993345e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCellControl-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class

MYOM2 PRSS23 ITGAL HLA-E

1.37e-0519933494b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCellmild_COVID-19-NK|mild_COVID-19 / disease group, cell group and cell class (v2)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-051993344854f25ee436e1cf577744373ffd87b1221d2b88
ToppCellCOVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass

MYOM2 PRSS23 ITGAL HLA-E

1.37e-051993345f914962e2572b0c6372465b81b7496fa663d93c
ToppCellCOVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-05199334d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-051993344820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCellHealthy_donor-NK|Healthy_donor / disease group, cell group and cell class (v2)

MYOM2 PRSS23 ITGAL HLA-E

1.37e-051993344892d85f7c8c00e5afdcea2cd7bae0074322fa52
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class

MYOM2 PRSS23 ITGAL HLA-E

1.40e-052003346560753d3df2f87860b52052d4881aa45410f666
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class

MYOM2 PRSS23 ITGAL HLA-E

1.40e-052003342281debd86e5d92e8fe0397aec9ef670800f7471
ToppCellproximal-Endothelial-Bronchial_Vessel_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PRSS23 RHOJ KIF17 HLA-E

1.40e-05200334b6666ade237c39bfde13987685567bad1762baec
ToppCellproximal-Endothelial-Bronchial_Vessel_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PRSS23 RHOJ KIF17 HLA-E

1.40e-052003342ecf7a38799c151ffb09f2677e38a4ffa354c1da
ToppCellControl-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class

MYOM2 PRSS23 ITGAL HLA-E

1.40e-05200334c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class

MYOM2 PRSS23 ITGAL HLA-E

1.40e-05200334f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCellproximal-3-Endothelial-Bronchial_Vessel_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PRSS23 RHOJ KIF17 HLA-E

1.40e-05200334038812912bb9f6c1359765614bb9fd138843a306
ToppCellBLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MYOM2 PRSS23 HLA-E

1.67e-041453336dd81d53d006fcc206a10969374a11c372f92133
ToppCell356C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 PRSS23 ITGAL

1.81e-0414933395b21d67d6c335330a508f78d5cc074fdaf92275
ToppCell367C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ZNF486 GABARAPL1 EPCAM

2.27e-041613338de421c61f4d5a6e05fdb20e4d230e2db98ee4d5
ToppCell390C-Lymphocytic-NK_cells-NK_cell_D|390C / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 ITGAL HLA-E

2.27e-04161333b60b4fd34a3ad4bf1813e6cc24aa7e04f9e53e4c
ToppCelldroplet-Heart-4Chambers|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYOM2 GABARAPL1 EPCAM

2.31e-041623335625ec6dae204d5537883f05ea546970628d10bb
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 ITGAL HLA-E

2.35e-04163333036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37
ToppCellPosterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

TMEM232 ITGAL STK26

2.35e-04163333218b9ba099cb27aa91c6b73bf89b44895f5dddc3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

HMCN2 RHOJ HLA-E

2.44e-04165333a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TARS3 CCPG1 NEB

2.44e-0416533379c6ad394266ff092029375883660028e944a3c8
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

MYOM2 LZTR1 NEB

2.52e-04167333e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZNF486 ITGAL STK26

2.57e-04168333187b98664843a304406f086ea696adbf32283d07
ToppCelldroplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EML2 INCENP STK26

2.57e-0416833319d2c763b50e7168dfa7449fc407489b055526c2
ToppCelldroplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EML2 INCENP STK26

2.57e-04168333fa198bd53b2d640d9a8684783bf5ca23314caae2
ToppCellASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

MYOM2 PRSS23 ITGAL

2.66e-0417033384705434234bf2fbb5256bd5a1f6ab54c01c5a51
ToppCellASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

MYOM2 PRSS23 ITGAL

2.75e-04172333c9e738c3540ee09b08805b1cdb66b4a0d9d40d33
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INCENP KIF17 UGDH

2.75e-04172333c06ca5d075937747952ed915c9db39a9f62072f9
ToppCellEndothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id

PRSS23 RHOJ KIF17

2.75e-041723338a527dff06d841a86c7eb04a1dd9630787294da4
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYOM2 NEB TMEM232

2.85e-041743334a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NEB KIF17 HLA-E

3.04e-0417833360263c0bb9de3a57ba2ba543262a2ace0066fd85
ToppCellmetastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass

NFYA RHOJ TMEM161B

3.09e-0417933356fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYOM2 BRF1 ITGAL

3.20e-041813335cecbafc29cc95896e6ccb2c74d9237b9aaece69
ToppCellcellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ZNF486 ITGAL TMEM161B

3.25e-041823338ccffcbae28c374fd4161fb0d4cf2c49fae557f6
ToppCell356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells)

MYOM2 PRSS23 HLA-E

3.25e-0418233352baef8173df0a55307c375674a37c2488066738
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS23 RHOJ HLA-E

3.30e-04183333a90ffd9c50caa65f537a2e441e37655e1b622327
ToppCellCOVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class

MYOM2 GABARAPL1 ITGAL

3.30e-04183333f593a89b0aa8fffdfa403769916facfd30358521
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS23 RHOJ HLA-E

3.30e-0418333313ad20ec140ef5b96fdace3369b5befc0f40bb76
ToppCelldroplet-Spleen-nan-3m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCPG1 CCDC88A EPCAM

3.41e-04185333ff95a45b7cb782961bb8f008b6b507af2d4cb8b7
ToppCelldroplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYOM2 PRSS23 UGDH

3.41e-0418533301bbe1e09f9ccae837a03ea2cdd168fa10800942
ToppCellControl-T_cells-NK_cells|Control / group, cell type (main and fine annotations)

MYOM2 ITGAL HLA-E

3.41e-04185333755c0998c729f462399f1d5e88adf4bfae31be30
ToppCellControl-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations)

PRSS23 RHOJ HLA-E

3.46e-04186333c6075fe84226b370c5139066793844ad33ae2db1
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRSS23 KIF17 HLA-E

3.46e-04186333e9d12f2fcd346fc8d00f7178324ea5997628df8a
DrugButylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A

NFYA INCENP CSPP1 KIAA0753

1.62e-041913344647_DN
DrugTriflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; PC3; HT_HG-U133A

EML2 CCDC88A GABARAPL1 INCENP

1.62e-041913341813_UP
DrugResveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A

LZTR1 NEB CSPP1 KIAA0753

1.66e-041923345509_DN
DrugTinidazole [19387-91-8]; Down 200; 16.2uM; HL60; HT_HG-U133A

NFYA EML2 CCDC88A KIF17

1.76e-041953342568_DN
DrugClomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; MCF7; HT_HG-U133A

NFYA LZTR1 INCENP CSPP1

1.76e-041953344994_DN
DrugQuinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; MCF7; HT_HG-U133A

EML2 LZTR1 NEB INCENP

1.76e-041953343179_DN
DrugTriamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A

NFYA LZTR1 CSPP1 KIAA0753

1.79e-041963341861_DN
DrugPimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

NFYA BRF1 NEB CSPP1

1.79e-041963343178_DN
DrugChlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A

BRF1 GABARAPL1 NEB CSPP1

1.83e-041973345360_UP
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A

LZTR1 BRF1 GABARAPL1 CSPP1

1.83e-041973341801_DN
DrugPHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A

NFYA LZTR1 BRF1 GABARAPL1

1.86e-041983347076_DN
DrugReserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A

NFYA LZTR1 INCENP CSPP1

1.86e-041983347323_DN
DrugOxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A

EML2 CCDC88A GABARAPL1 CSPP1

1.86e-041983345094_DN
DrugAdrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A

EML2 LZTR1 NEB KIAA0753

1.86e-041983343107_DN
DrugStreptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A

CASP5 LZTR1 GABARAPL1 CSPP1

1.86e-041983345837_UP
DrugPanthenol (D) [81-13-0]; Down 200; 19.4uM; PC3; HT_HG-U133A

LZTR1 BRF1 GABARAPL1 KHDRBS1

1.86e-041983341802_DN
DrugIsoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A

NFYA BRF1 INCENP CSPP1

1.86e-041983342246_DN
DrugPropantheline bromide [50-34-0]; Down 200; 9uM; HL60; HT_HG-U133A

EML2 LZTR1 CCDC88A CSPP1

1.86e-041983343013_DN
DrugBendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A

EML2 PRSS23 NEB INCENP

1.86e-041983343415_UP
DrugCoralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; PC3; HT_HG-U133A

LZTR1 CCDC88A BRF1 GABARAPL1

1.90e-041993346317_UP
DrugMethiothepin maleate [19728-88-2]; Up 200; 8.4uM; PC3; HT_HG-U133A

EML2 LZTR1 CCDC88A KIAA0753

1.90e-041993346312_UP
DrugNimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A

EML2 LZTR1 NEB ITGAL

1.90e-041993345421_DN
DrugBumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A

NFYA LZTR1 BRF1 NEB

1.90e-041993345542_DN
DrugPentolinium bitartrate [52-62-0]; Up 200; 7.4uM; HL60; HT_HG-U133A

NFYA CCDC88A NEB KHDRBS1

1.90e-041993342343_UP
DrugDenatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A

BRF1 NEB ITGAL CSPP1

1.94e-042003346502_UP
DiseaseFamilial aplasia of the vermis

CSPP1 KIAA0753

5.17e-0430332C0431399
Diseaseplasminogen activator inhibitor 1 measurement

MYOM2 TMEM232

1.67e-0354332EFO_0004792
DiseaseMicrocephaly

CCDC88A STAMBP

2.56e-0367332C0025958
Diseasetonsillectomy risk measurement

ITGAL CSPP1 HLA-E

3.03e-03260333EFO_0007924
Diseaserespiratory symptom measurement, COVID-19

STK26 UGDH

3.12e-0374332EFO_0007939, MONDO_0100096
Diseaselower face morphology measurement

MYOM2 PRSS23

6.63e-03109332EFO_0010948
Diseasepneumonia, COVID-19

STK26 UGDH

7.10e-03113332EFO_0003106, MONDO_0100096

Protein segments in the cluster

PeptideGeneStartEntry
IELKHKAREKPYDSK

EPCAM

146

P16422
GKDRKPKYIHNLLKA

NSRP1

96

Q9H0G5
KYLEKGKETLLHLEP

HLA-E

191

P13747
DKIKYPRKGHVEDVL

LZTR1

531

Q8N653
DLEDIFKKSKPRYHK

INCENP

876

Q9NQS7
KPKLGKRDYLEKAGE

RPS6KC1

231

Q96S38
HTPKERFYLKVKGKD

HMCN2

391

Q8NDA2
RQIKKELEHYKEKGE

CCDC88A

611

Q3V6T2
PLGEDYERKKHKLKE

CSPP1

111

Q1MSJ5
KEKPLTYEHGVKLAK

RHOJ

151

Q9H4E5
DGRKEKPVHFKEFRK

CCPG1

591

Q9ULG6
KKNHDEIYPIKKRED

CASP5

176

P51878
KKKILYEGTHLDPER

COX20

96

Q5RI15
KEDHPFEYRKKEGEK

GABARAPL1

6

Q9H0R8
KEVHPFEYRKKEGEK

GABARAPL3

6

Q9BY60
KAKEEELRKGGDPKY

KHDRBS1

206

Q07666
KRQGLFEKHEKPKYV

EML2

241

O95834
LKHGKEEPEEVQYKK

FOCAD

916

Q5VW36
EAEGKIPKERRKYLH

NFYA

286

P23511
KQKLELKEHPEKGVY

KIF17

156

Q9P2E2
PKIDIKIKDAIGRYH

TARS3

621

A2RTX5
KKDRKYNGHIESKPL

TMEM161B

61

Q8NDZ6
KEILKGLDYLHSEKK

STK26

126

Q9P289
DYALLELKKPHKRKF

PRSS23

246

O95084
YVKRKDPDALLKHVK

ITGAL

211

P20701
KYKIPDHRVERKESK

KIAA0753

136

Q2KHM9
KELDYERIHKKMLKP

UGDH

421

O60701
KREEKLHKQTKPYEL

TMEM232

636

C9JQI7
KHRDYKSAVIPEKKD

STAMBP

76

O95630
RIAKEKELGIYKEHK

BRF1

491

Q92994
HTEKKPLKYIEGDKA

ZNF486

176

Q96H40
LIPKLSKKDHGEYKA

MYOM2

1186

P54296
KVEGEKLKHKYTIDP

NEB

1506

P20929